Parthanatos: mitochondrial-linked mechanisms and therapeutic opportunities

被引:445
作者
Fatokun, Amos A. [1 ]
Dawson, Valina L. [2 ,3 ,4 ,5 ,6 ]
Dawson, Ted M. [2 ,3 ,4 ,5 ]
机构
[1] Univ Nottingham, Sch Biomed Sci, Inst Cell Signalling, Nottingham NG7 2UH, England
[2] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Neuroregenerat Program, Baltimore, MD USA
[3] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Stem Cell Program, Baltimore, MD USA
[4] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA
[5] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA
[6] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA
关键词
PARP-1; parthanatos; AIF; mitochondria; cell death; therapy; APOPTOSIS-INDUCING-FACTOR; FOCAL CEREBRAL-ISCHEMIA; POLY(ADP-RIBOSE) POLYMERASE INHIBITION; ADP-RIBOSE POLYMERASE; NITRIC-OXIDE SYNTHASE; NEURONAL CELL-DEATH; IN-VIVO MODELS; SPINAL-CORD; DNA-REPAIR; PHARMACOLOGICAL MANIPULATION;
D O I
10.1111/bph.12416
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cells die by a variety of mechanisms. Terminally differentiated cells such as neurones die in a variety of disorders, in part, via parthanatos, a process dependent on the activity of poly (ADP-ribose)-polymerase (PARP). Parthanatos does not require the mediation of caspases for its execution, but is clearly mechanistically dependent on the nuclear translocation of the mitochondrial-associated apoptosis-inducing factor (AIF). The nuclear translocation of this otherwise beneficial mitochondrial protein, occasioned by poly (ADP-ribose) (PAR) produced through PARP overactivation, causes large-scale DNA fragmentation and chromatin condensation, leading to cell death. This review describes the multistep course of parthanatos and its dependence on PAR signalling and nuclear AIF translocation. The review also discusses potential targets in the parthanatos cascade as promising avenues for the development of novel, disease-modifying, therapeutic agents. Linked ArticlesThis article is part of a themed issue on Mitochondrial Pharmacology: Energy, Injury & Beyond. To view the other articles in this issue visit
引用
收藏
页码:2000 / 2016
页数:17
相关论文
共 181 条
[1]  
Abdelkarim GE, 2001, INT J MOL MED, V7, P255
[2]  
de la Lastra CA, 2007, CURR PHARM DESIGN, V13, P933
[3]   THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: OVERVIEW [J].
Alexander, Stephen P. H. ;
Benson, Helen E. ;
Faccenda, Elena ;
Pawson, Adam J. ;
Sharman, Joanna L. ;
McGrath, John C. ;
Catterall, William A. ;
Spedding, Michael ;
Peters, John A. ;
Harmar, Anthony J. .
BRITISH JOURNAL OF PHARMACOLOGY, 2013, 170 (08) :1449-1458
[4]   Assignment of the poly(ADP-ribose) glycohydrolase gene (PARG) to human chromosome 10q11.23 and mouse chromosome 14B by in situ hybridization [J].
Amé, JC ;
Apiou, F ;
Jacobson, EL ;
Jacobson, MK .
CYTOGENETICS AND CELL GENETICS, 1999, 85 (3-4) :269-270
[5]   Poly(ADP-ribose) (PAR) polymer is a death signal [J].
Andrabi, Shaida A. ;
Kim, No Soo ;
Yu, Seong-Woon ;
Wang, Hongmin ;
Koh, David W. ;
Sasaki, Masayuki ;
Klaus, Judith A. ;
Otsuka, Takashi ;
Zhang, Zhizheng ;
Koehler, Raymond C. ;
Hurn, Patricia D. ;
Poirier, Guy G. ;
Dawson, Valina L. ;
Dawson, Ted M. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (48) :18308-18313
[6]   Iduna protects the brain from glutamate excitotoxicity and stroke by interfering with poly(ADP-ribose) polymer-induced cell death [J].
Andrabi, Shaida A. ;
Kang, Ho Chul ;
Haince, Jean-Francois ;
Lee, Yun-Il ;
Zhang, Jian ;
Chi, Zhikai ;
West, Andrew B. ;
Koehler, Raymond C. ;
Poirier, Guy G. ;
Dawson, Ted M. ;
Dawson, Valina L. .
NATURE MEDICINE, 2011, 17 (06) :692-U82
[7]   Mitochondrial and Nuclear Cross Talk in Cell Death Parthanatos [J].
Andrabi, Shaida A. ;
Dawson, Ted M. ;
Dawson, Valina L. .
MITOCHONDRIA AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISORDERS, 2008, 1147 :233-241
[8]   Mitochondrial release of apoptosis-inducing factor occurs downstream of cytochrome c release in response to several proapoptotic stimuli [J].
Arnoult, D ;
Parone, P ;
Martinou, JC ;
Antonsson, B ;
Estaquier, J ;
Ameisen, JC .
JOURNAL OF CELL BIOLOGY, 2002, 159 (06) :923-929
[9]   Impairment of the neuronal dopamine transporter activity in MPP+-treated rat was not prevented by treatments with nitric oxide synthase or poly(ADP-ribose) polymerase inhibitors [J].
Barc, S ;
Page, G ;
Barrier, L ;
Piriou, A ;
Fauconneau, B .
NEUROSCIENCE LETTERS, 2001, 314 (1-2) :82-86
[10]  
Berger N A, 1986, Basic Life Sci, V38, P357